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In humans, nasopharyngeal carriage of Streptococcus pneumoniae is common and although
primarily asymptomatic, is a pre-requisite for pneumonia and invasive pneumococcal disease
(IPD). Together, these kill over 500,000 people over the age of 70 years worldwide every year.
Pneumococcal conjugate vaccines have been largely successful in reducing IPD in young
children and have had considerable indirect impact in protection of older people in
industrialized country settings (herd immunity). However, serotype replacement continues
to threaten vulnerable populations, particularly older people in whom direct vaccine efficacy is
reduced. The early control of pneumococcal colonization at the mucosal surface is mediated
through a complex array of epithelial and innate immune cell interactions. Older people often
display a state of chronic inflammation, which is associated with an increased mortality risk
and has been termed ‘Inflammageing’. In this review, we discuss the contribution of an
altered microbiome, the impact of inflammageing on human epithelial and innate immunity to
S. pneumoniae, and how the resulting dysregulation may affect the outcome of
pneumococcal infection in older individuals. We describe the impact of the pneumococcal
vaccine and highlight potential research approaches whichmay improve our understanding of
respiratory mucosal immunity during pneumococcal colonization in older individuals.
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William Osler, a Canadian physician, who himself died of pneumonia, wrote in his book The
Principles and Practice of Medicine: “In the aged, the chances are against recovery. So fatal that it has
been termed the natural end of the old man” (Osler, 1892).
Much has changed since, with a huge global public health effort to reduce the burden of
pneumonia and invasive pneumococcal disease (IPD), particularly in young children. However, thegy | www.frontiersin.org May 2021 | Volume 11 | Article 6514741
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now outnumber those <5yrs and, by 2050, will outnumber those
aged 15–24yrs when there is predicted to be 426 million people
>80yrs (U.N, 2019). Community Acquired Pneumonia (CAP) is
common in older individuals, particularly men, with infection by
Streptococcus pneumoniae as the leading cause (Kaplan et al.,
2002; Janssens and Krause, 2004; Stupka et al., 2009). In 2016,
pneumococcal pneumonia was responsible for ~494,340 deaths
globally in individuals >70yrs (Collaborators, 2018).
Why older people are so vulnerable to disease caused by S.
pneumoniae is likely to be multifactorial including co-
morbidities, relative immunodeficiency, malnutrition and
defective swallowing (Janssens and Krause, 2004; Zalacain,
2004; Arndt, 2015). Disease follows pneumococcal carriage and
reported nasopharyngeal and oropharyngeal carriage rates in
older people vary between 0–39% (Krone et al., 2015; Adler et al.,
2020; Almeida et al., 2020; Smith et al., 2020; Yasuda et al., 2020).
Unlike adults aged 18–64yrs, older adults do not appear to
benefit from the natural immune effects of pneumococcal
colonization events that are thought to protect against re-
colonization and disease (Ferreira et al., 2013; Adler et al.,
2020). Older people often display a disorganised inflammatory
state, which is associated with an increased mortality risk
and has been termed ‘Inflammageing’ (Franceschi and
Campisi, 2014; Ferrucci and Fabbri, 2018). This may
compromise upper respiratory mucosal immunity, mediated by
the nasopharyngeal epithelium and other cellular and
soluble innate immune components (Simell et al., 2012;Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 2Wilson et al., 2015; Jochems et al., 2018; Jochems et al., 2019a;
Weight et al., 2019).
In this review we discuss the impact of inflammageing on
innate immunity to S. pneumoniae in older people, summarised
in Figure 1. We outline the impacts of the pneumococcal vaccine
in older individuals and experimental approaches which may
lead to deeper understanding of how the pneumococcus affects
this vulnerable population.PHYSIOLOGY AND AGEING
Pulmonary Physiology
In humans, there is a decrease in pulmonary elasticity, loss of
respiratory muscular strength, decreased ciliary beating and
mucus velocity with age (Ho et al., 2001; Janssens and Krause,
2004). These changes occur from a combination of genetic
predisposition, inflammageing and environmental exposure,
which involve a wide range of molecular and cellular changes
and impairment of cell-cell communications (Brandenberger
and Muhlfeld, 2017).
Microbiome
It is becoming increasingly apparent that the microbiome is
an important determinant of lung and gut homeostasis and
the development of disease, particularly in older individuals
(de Steenhuijsen Piters et al., 2016; Schenck et al., 2016;
Man et al., 2017; Ragonnaud and Biragyn, 2021). It remainsFIGURE 1 | The impact of pneumococcal infection on mucosal immunity in older individuals. The human respiratory epithelium includes many cell types all of which
contribute to the development of innate immunity through a physical barrier held together by junctional proteins, and a chemical barrier via secretions of mucus,
cytokines, chemokines, antimicrobial peptides, vitamin D and retinoic acid. Innate immune cells such as monocytes, neutrophils and MAIT cells are also present in
the mucosa. In older individuals, there is a loss of physical movement both at a mechanical elasticity level and a lack of cilia beating which impacts on mucus
clearance. This contributes towards increased prevalence of luminal factors such as cell debris, secreted factors, microbiota and pathogens such as S. pneumoniae
which trigger already elevated baseline levels of cytokines such as IL-6, IL-8 and TNFa. In younger adults, epithelial-derived secretion of anti-microbial peptides such
as cathelicidin and NFkB activation, leads to autophagy. Impaired autophagy and type 1 interferon responses in older individuals may lead to suppressed IFNb
levels, increasing pneumococcal load. Increased expression of epithelial senescence markers and pneumococcal ligands such as PAFr in older people enhances
pneumococcal colonization, influencing adhesion, micro-invasion and transmigration potential. Vitamin D deficiency in older people may affect epithelial barrier
integrity. In younger adults, disruption to barrier function after pneumococcal infection affected the expression of junctional proteins such as Claudins. In older adults,
dysregulation of barrier may enhance rates of pneumococcal transmigration, infiltration of innate immune cells and inflammation. Although MAIT cells are rare in the
airway of older individuals, neutrophil prevalence is enhanced, which elevates degranulation and reactive oxygen species levels following pneumococcal infection.
However, neutrophil ability for opsonophagocytosis and chemotaxis is impaired in older individuals. Monocyte function may also be impaired in signal transduction
and secrete less IL-6, IL-8 and TNFa during infection, in comparison to younger adults. PNE cell, pulmonary neuroendocrine cell; AMP, anti-microbial peptides.
Created with Biorender.com.May 2021 | Volume 11 | Article 651474
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microbiota represent a cause or consequence of pneumonia (de
Steenhuijsen Piters et al., 2016). Older individuals with
pneumonia exhibit increased abundance of species such as S.
pneumoniae, Rothia and Lactobacilli, but decreased overall
anaerobic bacterial diversity in the upper respiratory tract
(URT) (de Steenhuijsen Piters et al., 2016). In a human
experimental pneumococcal challenge model (EHPC), low
density pneumococcal carriage was associated with a stable
mucosal microbiome (baseline presence of Corynebacterium/
Dolosigranulum species) and a less pro-inflammatory phenotype
(de Steenhuijsen Piters et al., 2019). Whether different
pneumococcal strains interact differently with the respiratory
microbiome during colonization (Cremers et al., 2014) and how
this affects older individuals, remains to be determined. The role
of intestinal microbiota on lung susceptibility to pneumococcal
infection also warrants further investigation in humans as
murine studies suggest that Nod-stimulating microbiota in the
gut induce GMCSF-dependent immunity, which influences
alveolar macrophage function during pneumococcal infection
(Schuijt et al., 2016; Brown et al., 2017).
Inflammageing
An imbalance of cytokine expression in older individuals is
referred to as “inflammageing”, where damage to the tissue,
changes in composition of the microbiome and cellular and
immune senescence, all contribute to this state of chronic
inflammation (Franceschi and Campisi , 2014). The
contributors to inflammageing may include microbial
translocation, chronic infections, mitochondrial dysfunction
and accumulation of DNA damage (Fulop et al., 2017; Ferrucci
and Fabbri, 2018). This increased inflammation extends to the
lungs, as healthy individuals >65yrs have elevated levels of IL-6,
IL-8 and higher numbers of neutrophils in bronchoalveolar
lavage (BAL) samples (Thompson et al., 1992; Meyer et al.,
1996). The increased susceptibility to respiratory tract infections
has also been linked to the heightened inflammatory status in
older people. In a large prospective study of people aged 70-
79yrs, being in the highest tertile for systemic IL-6 and TNF
levels was associated with 1.6-1.7-fold increased risk for
developing CAP (Yende et al., 2005). Inflammation, in
particular IL-6 levels, at time of admission to hospital is alsoFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 3associated with CAP disease severity (Glynn et al., 1999; Antunes
et al., 2002). Whether this represents more severe disease, or a
pre-existing heightened inflammatory state is uncertain. For
example, at admission, in a cohort of 22 patients with
pneumonia, of which 19 had confirmed S. pneumoniae,
patients <55yrs had increased levels of IL-6 compared to
patients >68yrs (Bruunsgaard et al., 1999). However, at 7 days
post admission, pro-inflammatory cytokines TNF and soluble
TNF receptor I remained elevated in older adults, while they had
returned to baseline in young adults. This increased
inflammatory state with age may therefore contribute to
dysregulation of immunomodulation of innate immune cells
such as neutrophils, cytokines and chemokines (Williams et al.,
2015) and ultimately, pneumococcal colonization, increasing the
chance of IPD in older individuals.EPITHELIAL CELL FUNCTION
AND AGEING
The nasopharyngeal epithelium provides the first line of defense
against respiratory pathogens. An intact physical barrier,
together with epithelial secretions of mucus, anti-microbial
peptides and proteins, chemokines and cytokines, forms the
basis of epithelial-derived innate immunity (Figure 1). Hence,
age related alterations in epithelial responses would have
profound effects on pneumococcal colonization, as
summarized in Table 1.
Epithelial Cell Activation
S. pneumoniae binds to a variety of epithelial receptors including
Keratin 10, laminin receptor and platelet-activating factor
receptor (PAFr), the expression of which is altered in older
individuals, thus potentially influencing pneumococcal
adherence and susceptibility towards disease. For example,
levels of Keratin 10, laminin receptor and PAFr are elevated in
aged mice, human lung tissue and senescent A549 cells
(Hinojosa et al., 2009; Shivshankar et al., 2011) which could
contribute to altered outcomes after pneumococcal colonization.
Pneumococcal micro-invasion of the epithelium in vitro is also
associated with epithelial secretion of cytokines and chemokinesTABLE 1 | Epithelial cell changes and ageing in the context of pneumococcal infection.
Molecular changes Pneumococcal outcome Impact on epithelial barrier
↑Keratin 10, laminin receptor, PAFr expression ↑ Pneumococcal adherence, micro-invasion and toxin
concentrations
↑ Epithelial damage, inflammation and immune cell
recruitment
↓ Claudin-5, -7, -10, Occludin, ZO-1, VE-cadherin
expression
↑ Pneumococcal transmigration across the epithelial
barrier
↑ Barrier permeability, NFkB activation, inflammation
and immune cell recruitment
↑Claudin 2 expression ↓ Transepithelial electrical resistance
↓ Vitamin D signalling ↑ Epithelial damage, inflammation and immune cell
recruitment
↓ LL-37, b defensin -2, -3, -4, S100A7, -8, -9,
Lipocalin and RNase 7 secretion
↑ Pneumococcal load and toxin concentrations ↓Autophagy, NLRP3 inflammasome activation
↑ Or ↓ IL-6 production ↓ Or ↑ Effects on pneumococcal-epithelial associations,
micro-invasion and transmigration
↓ Or ↑ Affecting barrier permeability, proliferation and
epithelial repairMay 2021 | Volume 11 | Article 651474
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including Toll receptor cascades, NFkB and MAPK activation
(Weight et al., 2019). In the EHPC model, an epithelial
transcriptomic signature that was associated with bacterial
clearance has been identified, indicating the involvement of
epithelial activation in the control of pneumococcal
colonization (Weight et al., 2019). Furthermore, in vitro
epithelial cell models reveal that activation of p65, upregulation
of the histone demethylase KDM6B and IL-11 secretion are
associated with protection from epithelial damage following
pneumococcal infection (Connor et al., 2020). We therefore
speculate that in older adults, where pneumococcal micro-
invasion and cellular senescence may be enhanced,
dysregulation of these pathways and regulatory mechanisms
could exacerbate invasive disease.
Mucosal Barrier Function: The expression profiles of
intercellular junctional proteins such as Claudins, ZO-1 and
E-Cadherin, determine the permissiveness of the respiratory
epithelium to the passage of microbes across the barrier.
Changes in epithel ia l junctional expression during
pneumococcal infection leads to structural reorganization of
the barrier. For example, in vitro infection of human
nasopharyngeal cells with S. pneumoniae is initially associated
with decreased permeability to 4kDa FITC-dextran, indicating a
strengthened barrier (Weight et al., 2019). However, over time
(>8 hours post-infection, when bacterial replication and autolysis
have also occurred) barrier integrity is altered, demonstrated
through decreased expression of Occludin, ZO-1, Claudin-5 and
VE-cadherin in the alveoli epithelium and endothelium in
younger adults lung explants (Peter et al., 2017). Furthermore,
downregulation of Claudin-7 and Claudin-10 in human and
murine epithelial cells, led to increased pneumococcal
transmigration across the epithelial barrier (Clarke et al., 2011).
The vitamin D receptor (VDR) regulates epithelial barrier
function (Chen et al., 2018). In Salmonella infected VDR-/- mice,
Claudin 2 upregulation was associated with leaky intestinal
barrier, increased pathology and upregulation of NFkB (Zhang
et al., 2019), a critical regulator of inflammageing (Salminen et al.,
2008) and tight junction protein expression (Ward et al., 2015).
In the older human intestine, Claudin-2 upregulation has been
detected, which was accompanied by decreased transepithelial
electrical resistance and increased permeability (Man et al., 2015).
Activation of NFkB following pneumococcal infection is widely
reported (Malley et al., 2003; Weight et al., 2019), and Vitamin D
deficiency is more severe in older generations (Hirani and
Primatesta, 2005; Jolliffe et al., 2013), and there is evidence to
suggest that supplementation of Vitamin D could be beneficial in
boosting immunity and reducing acute respiratory infections
(Martineau et al., 2017; Chambers et al., 2021). Whether
regulation and junctional protein responses in the URT are
altered with age in humans, and how this contributes to control
of pneumococcal colonization, remains to be determined.
Antimicrobial Peptides and
Proteins (AMPs)
An important factor of epithelial innate immunity includes
AMPs that neutralize toxins and eliminate pathogensFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 4(Hiemstra, 2001). Infection of human corneal epithelial cells
with pneumococcus induced NFkB activation leading to the
secretion of LL-37, b defensin -2, -3, -4, S100A7, S100A8,
S100A9, Lipocalin and RNase 7 (Sharma et al., 2019). LL-37
plays a role in wound healing, can induce autophagy in a 1,25-
dihydroxyvitamin D3 dependent manner, can activate the
NLRP3 inflammasome in a model of P. aeruginosa and, is
bactericidal against S. pneumoniae and Mycobacterium
tuberculosis (Nijnik and Hancock, 2009; Yuk et al., 2009;
McHugh et al., 2019; Sharma et al., 2019). Older individuals
maintain similar levels of baseline production of cathelicidins
and b defensin 2 in serum compared to younger adults
(Castaneda-Delgado et al., 2013). However, in aged mice,
CRAMP expression, the murine homolog of LL-37, was not
upregulated following pneumococcal infection, compared to
younger adults (Krone et al., 2013). This suggests a potential
dysregulation of AMPs in older individuals and the implications
for the control of S. pneumoniae at the mucosal surface warrants
further investigation.
Cytokines and Chemokines
AMPs also induce the secretion of cytokines and chemokines like
IL-6 and IL-8 from nasal epithelial cells, in an NFkB dependent
manner (Pistolic et al., 2009). One might predict that given
elevated levels of cytokines such as IL-6 and TNFa in older
individuals (Yende et al., 2005; Man et al., 2015), epithelial cell
responses may also differ in the response to pneumococcal
carriage. IL-6 is a pleiotropic cytokine and so elevated baseline
secretion in older individuals may either enhance or weaken
barrier integrity upon pathogenic challenge. For example, IL-6
regulates the expression of tight junction proteins such as
Claudin 2 and increases intestinal barrier permeability (Suzuki
et al., 2011; Man et al., 2015). This could also occur in the
respiratory setting, which may increase pneumococcal
transmigration across the epithelial barrier. Alternatively, IL-6
is also known to confer epithelial repair and promote
proliferation (Kuhn et al., 2014), which may inhibit
pneumococcal adherence to the epithelium. For example, co-
infection with Influenza A increases susceptibility to S.
pneumoniae in both adult and older mice and in younger
adults, characterized by increased bacterial burden in the URT
(Mina et al., 2014; Jochems et al., 2018; Gou et al., 2019). In the
murine study, IL-6 production was required to maintain barrier
function and macrophage phagocytic function, which played a
role in pneumococcal control and clearance (Gou et al., 2019).
Although secreted by infected human nasopharyngeal cells in
vitro (Weight et al., 2019), levels of epithelial IL-6 secretion in
vivo have not been directly investigated in adults or
older individuals.INNATE IMMUNITY AND AGEING
The degree of inflammageing likely influences the functional
responses of monocytes/macrophages, neutrophils andMucosal-
associated invariant T (MAIT) cells to S. pneumoniae, which in
turn, may be detrimental in controlling the outcome ofMay 2021 | Volume 11 | Article 651474
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summarized in Table 2.
Monocytes and Macrophages
TLR1 levels are reduced on monocytes from older adults and
TLR1/2 specific stimulation using Pam2SCK4 is associated with
reduced responses in monocytes from older people (van Duin
et al., 2007). Indeed, cytokine responses to pneumococcal or
relevant ligands also appear decreased with age. Frail older
individuals have increased baseline production of TNF by
intermediate monocytes in particular, but show an impaired
induction upon TLR1/2 or TLR4 stimulation (Hearps et al., 2012;
Verschoor et al., 2014b). Upon heat-killed pneumococcal
stimulation however, monocyte-derived macrophages in frail
older people produce less TNF, IL-6, IL-1b and IL-8 and have
a reduced capacity to kill S. pneumoniae. This is possibly related
to defective PI3K-AKT signaling (Verschoor et al., 2014a), and/
or insufficient activation of the NLRP3 inflammasome, as
demonstrated in bone marrow derived macrophages from aged
mice (Cho et al., 2018).
In younger adults, infiltration of classical monocytes into the
nasal mucosa in the EHPC model coincides with initiation of
pneumococcal clearance, while nasal myeloid cytokines correlate
with clearance of colonization (Jochems et al., 2018). The impact
of the respiratory monocyte/macrophage dysfunction described
above on pneumococcal control in older people is not fully
understood. However, altered monocyte subsets are an
important contributor to a reduced ability to prevent
pneumococcal infection in older people (Puchta et al., 2016).
For example, reduced cytokine production to TLR1/2 agonists
seem to be mediated by changes in CD14++ CD16+ intermediate
and CD14+ CD16+ non-classical monocytes (Nyugen et al.,
2010). In addition, alveolar macrophage numbers are higher in
BAL samples from healthy older adults compared to younger
adults (Thompson et al., 1992; Meyer et al., 1996), although how
this affects innate immune responses to S. pneumoniae
is unknown.
Murine studies have also identified age-related functional
differences in monocyte/macrophage interactions with S.
pneumoniae that may be relevant for disease pathogenesis.
Puchta et al. demonstrated that TNF is a crucial mediator of
the susceptibility to pneumococcal infections in inflammageing,
as well as the alterations in monocyte subsets (Puchta et al.,
2016). Increasing TNF with age led to premature egress of pro-
inflammatory monocytes from bone marrow and increased levels
of intermediate CD14++ CD16+ monocytes. Specific depletionFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 5of these monocytes or reduction in TNF levels enhanced
immunity to pneumococcal infection and increased clearance
in old mice (Puchta et al., 2016). Koppe found that following
sensing of pneumococcal dsDNA by murine macrophages,
STING (“stimulator of IFN genes”) binds to TBK1 (TANK-
binding Kinase 1), leading to IRF3 (Interferon Regulatory
Transcription Factor 3) activation and production of IFNb,
which assists pneumococcal clearance (Koppe et al., 2012). In
aged mice, there is less STING/TBK1/IRF3 mRNA and protein
expression compared to young mice infected with S. pneumoniae
(Mitzel et al., 2014). This was associated with lower levels of
IFNb and higher bacterial burden in the lung, thought to be due
to age-associated stress of the endoplasmic reticulum, resulting
in increased autophagy-related protein 9a-STING complex
formation (Mitzel et al., 2014), preventing STING complex
formation with TBK1 (Saitoh et al., 2009).
Neutrophils
There is a large body of evidence from both murine and human
studies showing the importance of neutrophils in protecting
against pneumococcal colonization of the nasopharynx (Lu
et al., 2008; Weinberger et al., 2009; Jochems et al., 2018;
Nikolaou et al., 2018). Impaired functional responses of
neutrophils in older individuals may therefore also be
detrimental during pneumococcal infection.
In the nose and lungs of healthy older people, neutrophils are
highly abundant (Thompson et al., 1992; Meyer et al., 1996;
Reiné et al., 2019). Excessive neutrophil recruitment to the lung
following infection can mediate tissue damage and may
exacerbate inflammation in older people (Menter et al., 2014).
In frail older individuals, neutrophils have an immature profile
with increased levels of intracellular reactive oxygen species
(ROS) and cell surface expression of proinflammatory markers
like CD11b (Verschoor et al., 2015). They have an impaired
capacity to produce neutrophil extracellular traps (Hazeldine
et al., 2014) and altered chemotaxis responses to respiratory
infection, which leads to prolonged production of proteinase and
a pro-inflammatory milieu (Sapey et al., 2014; Sapey et al., 2017).
Neutrophils in older individuals may also be impaired in their
opsonophagocytotic ability to several bacterial pathogens
including S. pneumoniae and S. aureus (Wenisch et al., 2000;
Butcher et al., 2001; Simell et al., 2011). Interestingly, vitamin E
supplementation in aged mice prevented neutrophil migration
and mortality during pneumococcal pneumonia (Ghanem et al.,
2015), suggesting that regulating neutrophil activity in older
individuals could be beneficial to the host.TABLE 2 | Changes in Innate Immunity with age.
Changes with age Monocytes/Macrophage Neutrophils MAIT cells
Prevalence ↑ Alveolar macrophages ↑ Nose and lungs ↓ Blood
↑ CD14++CD16+ monocytes ↓Total CD8+ T cells in nasal mucosa
Cellular changes ↓ TLR1/2/4 ↑ CD11b ↑ Clonal expansion
↓STING/TBK1/IRF3 ↓Extracellular traps, migration and opsonophagocytosis
↓ Inflammasome activation
Cytokine responses ↑ TNF baseline ↑ ROS, Proteinase
↓TNF, IL-6, IL-1b, IL-8, IFNbMay 2021 | Volume 11 | Article 651474
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Unconventional, innate-like T cells called MAIT cells, play
important roles in the defense against bacterial and viral
infections. Recently, studies with the EHPC model
demonstrated that blood and nasal MAIT cells were associated
with protection from pneumococcal colonization (Jochems et al.,
2019b). They can be activated by conserved bacterial ligands
derived from vitamin B (riboflavin) biosynthesis or indirectly via
cytokines (Godfrey et al., 2019; Toubal et al., 2019). MAIT cells
recognize precursors of the riboflavin synthesis pathway after
presentation via MHC class I–related protein 1 (MR-1). This
pathway is highly conserved in the pneumococcal genome, and
MAIT cells can respond to pneumococcal isolates in both MR-1
dependent and independent manners (Kurioka et al., 2018).
MAIT cells are depleted from blood in old age, with levels
progressively dropping from 3-5% of T cells in young
adulthood to below 1% in older adults (Novak et al., 2014;
Walker et al., 2014; Loh et al., 2020). Remaining MAIT cells in
this population show clonal expansion, similar to conventional
CD8 T cells, and increased basal inflammation, although they
retain potent anti-microbial function (Loh et al., 2020). There
appears to be a substantial depletion of total CD8+ T cells from
the nasal mucosa in older adults (Reiné et al., 2019) and the ratio
of CD4/CD8 T cells increases in the lung in middle age (Meyer
et al., 1996). Therefore, as MAIT cells are predominantly found
within the CD8+ T cell compartment, we postulate that there is
loss of MAIT cells at the mucosal surface in older individuals
which negatively impacts on the control of pneumococcal
colonization. This warrants further investigation.
Th17 and T Regulatory Cells (Tregs)
In murine models, a Th17-mediated recruitment of monocytes
and neutrophils leads to clearance of S. pneumoniae colonization
(Lu et al., 2008; Zhang et al., 2009). Some human studies also
suggest a role for Th17 cells in protection against colonization
showing increased ratios of pneumococcal-specific Th17/Tregs
with increasing age as carriage rates decrease (Mubarak et al.,
2016) and a SNP in the IL17A gene associated with ~2-fold
increased risk of pneumococcal colonization in children in the
first year of life (Vuononvirta et al., 2015). However, a protective
role for Th17 cells in humans has not been fully substantiated.
We have shown acquisition of pneumococcal antigen-specific
tonsillar Th1 T cells but not Th17 cells with age (Pido-Lopez
et al., 2011). In the EHPC model, Th17 cells were found in the
lung after colonization, which associated with increased bacterial
killing in macrophages (Wright et al., 2013), but were not
identified in the nasopharynx. Higher Th17 responses were
found in children from Bangladesh with high carriage rates,
compared to children from Sweden with lower carriage rates
(Lundgren et al., 2012). In HIV+ individuals in Malawi where
carriage rates are high, there was no evidence of a Th17
protective phenotype (Glennie et al., 2013). Furthermore,
colonization by S. pneumoniae has been associated with
decreased Th17/Treg ratios in children, possibly mediated by
TGF-b induction leading to regulatory responses (Zhang et al.,
2011; Neill et al., 2014; Jiang et al., 2015). Stimulation of PBMCsFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 6from individuals of different ages with three different
pneumococcal proteins revealed a non-significant decrease in
responses of older adults, although polyfunctionality (co-
production of IFNg by same donor) was decreased (Schmid
et al., 2011). In older adults, total Th17 numbers in blood are
decreased and total Treg numbers increased (van der Geest et al.,
2014). Together, these observations highlight that a role of Th17
cells in conferring protection against colonization in humans
remains unclear. Further investigations of mucosal Th17 and
Tregs responses in older people using longitudinal studies and
the EHPC model are required.PNEUMOCOCCAL VACCINES IN
OLDER PEOPLE
With the high risk of S. pneumoniae infection in the older
population and an ageing population, there is an urgent need
for effective vaccine approaches to protect this vulnerable group.
The 23-valent pneumococcal polysaccharide vaccine (PPV23) is
widely used in richer countries to prevent pneumococcal disease
in older people and often administered alongside the influenza
vaccine. Observational studies have suggested that PPV23
reduces the incidence of pneumococcal pneumonia and
vaccine-serotype IPD and mortality in older individuals by
29% - 57% (Christenson et al., 2001; Andrews et al., 2004;
Spindler et al., 2008; Suzuki et al., 2017). However, meta-
analyses have suggested that PPV23 may only be beneficial
against IPD, with no effect against the far more common non-
bacteremic pneumonia (Moberley et al., 2013; Latifi-Navid et al.,
2018). Along with its disputed efficacy against pneumonia,
PPV23 has no protective effect against pneumococcal
colonization (Adler et al., 2020).
PPV23 induces the production of anti-capsular antibodies via
a T-cell-independent mechanism. Pneumococcal conjugate
vaccines (PCV) induce higher antibody levels and longer-term
immune memory via carrier protein mediated T-cell-dependent
mechanisms. In controlled infection studies of young adults,
PCV13 reduced pneumococcal colonization (Collins et al., 2015;
German et al., 2019). Together with routine vaccination of
children with PCV, which reduces carriage and transmission,
they protect older people from S. pneumoniae infections through
herd immunity. However, as serotype replacement threatens the
efficacy of the vaccine (Lewnard and Hanage, 2019), new
strategies to protect older individuals are required.
Clinical trials have confirmed that PCV13 can reduce the
incidence of vaccine-serotype colonization in older adults,
though the effect did not persist beyond six months (van
Deursen et al., 2018). This impact of PCV13 on pneumococcal
colonization may therefore be expected to overcome some of the
deficiencies of PPV23 in its activity against pneumonia and, in
adults >65yrs, PCV13 indeed demonstrated a 45% efficacy
against non-bacteremic CAP caused by the vaccine serotypes,
along with a 75% efficacy against IPD (Bonten et al., 2015).
PCV20 represents a potential further advance due to the increase
in serotype coverage, and results of phase 3 trials in olderMay 2021 | Volume 11 | Article 651474
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(Pfizer, 2019).
The process of inflammageing in older individuals which
includes physical airway alterations, shifts in the microbiome
coupled with effects on the epithelium and innate immunity, will
likely contribute to a decreased efficacy of the pneumococcal
vaccines. Therefore, understanding in more detail the underlying
molecular and cellular mechanisms could help identify
interventions to enhance immune responses in this population
group. Novel vaccine approaches such as targeting pneumococcal
proteins, using whole cell inactivated or attenuated strains, and
with new adjuvants or immunomodulating agents to overcome
the effects of inflammageing, may enhance protection against IPD
in older individuals (Feldman and Anderson, 2014; Ramos-
Sevillano et al., 2020; Wagner and Weinberger, 2020). Potential
novel mucosal immunomodulating interventions include statins,
vitamin supplementation and changes to the nasal microbiome to
boost mucosal immunity, but these need to be first supported by
high quality clinical trial data. In the meantime, high levels of
pneumococcal vaccine uptake by adults alongside PCV
vaccination of younger individuals to generate herd immunity
will have the greatest effect on the morbidity and mortality
associated with S. pneumoniae in older individuals. Additional
important preventative strategies include annual health checks
and smoking cessation as heart disease, diabetes mellitus and
smoking increase the incidence of CAP (Torres et al., 2015).DISCUSSION
The immune dysregulation associated with inflammageing has
wide ranging effects on the control of pneumococcal colonization
and the transition to invasive disease. To better define these
processes, in parallel with murine models and in vitro culture
systems, the EHPC model provides a unique and safe
opportunity to investigate in detail the cellular and molecularFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 7changes involved. The model also enables investigation of
pneumococcal-epithelial-innate immune cell interactions and
activation. For example, the model can be used to assess
changes in pneumococcal micro-invasion of the epithelium
and characterize subsequent alterations in epithelial-derived
innate immune responses following pneumococcal infection in
older individuals. Transcriptomic and metabolomic approaches
applied to these systems will lead to further understanding of
molecular changes that occur during inflammageing and how
they influence pneumococcal infection (Valdes et al., 2013;
Giamarellos-Bourboulis et al., 2020).
In the last 128 years since William Osler’s observations on
pneumonia, advances in the understanding of mucosal immune
protection against pneumococcal disease in older individuals has
progressed considerably. However, it is evident that there is still
much more that needs to be discovered if we are to reduce the
burden of pneumococcal disease in this vulnerable population.AUTHOR CONTRIBUTIONS
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